EQT Ventures, a prominent venture capital firm, has embraced artificial intelligence (AI) to revolutionize its investment strategies. Their flagship AI initiative, Motherbrain, was launched in 2016 and has since become integral to the firm’s operations. Motherbrain leverages vast datasets and…
CVC Capital Partners plc, a leading global private markets manager, specializes in private equity, secondaries, credit, and infrastructure. With 29 local offices and €193 billion in assets under management, CVC identifies and creates value in investment opportunities. Its private equity…
Goldman Sachs, a global leader in investment banking, is at the forefront of leveraging artificial intelligence (AI) to enhance its operational efficiency. By the end of July 2024, Goldman Sachs will complete the rollout of its first generative AI tool…
Morgan Stanley, a global leader in financial services, has integrated generative artificial intelligence (AI) into its operations, opting for homegrown solutions over off-the-shelf tools. This strategic move aims to enhance the efficiency and productivity of its financial advisors. Key Takeaways…
Wells Fargo, a multinational financial services company, has embarked on a journey to integrate artificial intelligence (AI) into its operations, enhancing customer experiences and improving operational efficiencies. Under the leadership of Ather Williams III, the Senior Executive Vice President and…
Bank of America (BoA) is undergoing a significant technological transformation, committing $4 billion to technology initiatives in 2024, with a strong emphasis on generative AI projects. This substantial investment is part of the bank’s broader $12 billion annual technology budget,…
JPMorgan Chase, the largest bank in the United States by assets, has emerged as a leader in the adoption and implementation of artificial intelligence (AI) within the banking sector. With a significant investment in technology and a strategic approach to…
Pfizer, a global leader in the biopharmaceutical industry with a revenue of $59 billion, has embarked on a comprehensive integration of artificial intelligence (AI) across its operations. This initiative spans multiple functions, including People Experience (HR), Talent Acquisition (Candidate Experience),…
At Amgen, artificial intelligence (AI) is more than just a technological advancement—it’s a pivotal force transforming the future of biotechnology. Under the guidance of David Reese, Amgen’s first chief technology officer, AI is being integrated across all operational levels to…
AstraZeneca, a prominent global biopharmaceutical company, is dedicated to researching, developing, manufacturing, and marketing prescription drugs and vaccines across several key therapeutic areas, including oncology, cardiovascular, renal, metabolism, respiratory, and immunology. In 2022, AstraZeneca reported revenues of $42.67 billion and…
Novo Nordisk, a global pharmaceutical leader with a century-long legacy, is revolutionizing drug development through the strategic integration of artificial intelligence (AI) and advanced analytics. Spearheaded by Dr. Faisal M. Khan, the corporate vice president of AI and analytics, Novo…
Eli Lilly and Company has embarked on a groundbreaking collaboration with OpenAI to harness generative AI technology for the discovery of novel antimicrobials aimed at combating drug-resistant bacteria. This strategic initiative addresses the pressing global health threat of antimicrobial resistance…